Dexcom Inc Stock Performance
| DXCM Stock | USD 74.46 0.78 1.04% |
DexCom has a performance score of 1 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 0.23, which means not very significant fluctuations relative to the market. As returns on the market increase, DexCom's returns are expected to increase less than the market. However, during the bear market, the loss of holding DexCom is expected to be smaller as well. DexCom Inc right now shows a risk of 1.94%. Please confirm DexCom Inc skewness, and the relationship between the potential upside and rate of daily change , to decide if DexCom Inc will be following its price patterns.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental indicators, DexCom is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors. ...more
Actual Historical Performance (%)
One Day Return (1.91) | Five Day Return (3.27) | Year To Date Return (40.66) | Ten Year Return 470.63 | All Time Return 2.4 K |
Last Split Factor 4:1 | Last Split Date 2022-06-13 |
1 | DexCom, Inc. Sued for Securities Law Violations - Investors Should Contact Levi Korsinsky for More Information - DXCM | 10/21/2024 |
2 | DexCom Reports Q3 Earnings What Key Metrics Have to Say | 10/24/2024 |
3 | Quintet Private Bank Europe S.A. Raises Stock Holdings in DexCom, Inc. | 11/04/2024 |
4 | WoodTrust Financial Corp Sells 1,750 Shares of DexCom, Inc. | 11/07/2024 |
5 | Are Investors Undervaluing DexCom, Inc. By 44 | 11/08/2024 |
6 | U.S. stocks lower at close of trade Dow Jones Industrial Average down 0.86 | 11/12/2024 |
7 | DexCom Inc Shares Down 2.6 percent on Nov 13 | 11/13/2024 |
8 | Dexcom Helps People With Diabetes Take the First Step to Discover What Theyre Made Of on World Diabetes Day | 11/14/2024 |
9 | DexCom, Inc. Among 12 High Growth Large Cap Stocks to Buy Now | 11/15/2024 |
10 | Dexcom invests 75M in Oura as companies strike health monitoring partnership | 11/19/2024 |
11 | Disposition of 652 shares by Michael Brown of DexCom at 69.55 subject to Rule 16b-3 | 11/21/2024 |
| Begin Period Cash Flow | 643.3 M |
DexCom |
DexCom Relative Risk vs. Return Landscape
If you would invest 7,367 in DexCom Inc on August 24, 2024 and sell it today you would earn a total of 79.00 from holding DexCom Inc or generate 1.07% return on investment over 90 days. DexCom Inc is currently generating 0.0349% in daily expected returns and assumes 1.9354% risk (volatility on return distribution) over the 90 days horizon. In different words, 17% of stocks are less volatile than DexCom, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
DexCom Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for DexCom's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as DexCom Inc, and traders can use it to determine the average amount a DexCom's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.018
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | DXCM |
Estimated Market Risk
| 1.94 actual daily | 17 83% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average DexCom is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of DexCom by adding it to a well-diversified portfolio.
DexCom Fundamentals Growth
DexCom Stock prices reflect investors' perceptions of the future prospects and financial health of DexCom, and DexCom fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on DexCom Stock performance.
| Return On Equity | 0.32 | ||||
| Return On Asset | 0.0606 | ||||
| Profit Margin | 0.17 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 29.49 B | ||||
| Shares Outstanding | 390.6 M | ||||
| Price To Earning | 245.31 X | ||||
| Price To Book | 14.85 X | ||||
| Price To Sales | 7.36 X | ||||
| Revenue | 3.62 B | ||||
| Gross Profit | 1.88 B | ||||
| EBITDA | 916.7 M | ||||
| Net Income | 541.5 M | ||||
| Cash And Equivalents | 2.37 B | ||||
| Cash Per Share | 6.14 X | ||||
| Total Debt | 2.59 B | ||||
| Debt To Equity | 1.17 % | ||||
| Current Ratio | 3.77 X | ||||
| Book Value Per Share | 5.07 X | ||||
| Cash Flow From Operations | 748.5 M | ||||
| Earnings Per Share | 1.65 X | ||||
| Market Capitalization | 29.08 B | ||||
| Total Asset | 6.26 B | ||||
| Retained Earnings | 1.02 B | ||||
| Working Capital | 2.87 B | ||||
| Current Asset | 231.3 M | ||||
| Current Liabilities | 66.9 M | ||||
About DexCom Performance
By examining DexCom's fundamental ratios, stakeholders can obtain critical insights into DexCom's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that DexCom is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 153.18 | 160.84 | |
| Return On Tangible Assets | 0.09 | 0.09 | |
| Return On Capital Employed | 0.13 | 0.13 | |
| Return On Assets | 0.09 | 0.09 | |
| Return On Equity | 0.26 | 0.27 |
Things to note about DexCom Inc performance evaluation
Checking the ongoing alerts about DexCom for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for DexCom Inc help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| DexCom Inc is unlikely to experience financial distress in the next 2 years | |
| Over 97.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from simplywall.st: Disposition of 652 shares by Michael Brown of DexCom at 69.55 subject to Rule 16b-3 |
- Analyzing DexCom's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether DexCom's stock is overvalued or undervalued compared to its peers.
- Examining DexCom's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating DexCom's management team can have a significant impact on its success or failure. Reviewing the track record and experience of DexCom's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of DexCom's stock. These opinions can provide insight into DexCom's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in DexCom Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of DexCom. If investors know DexCom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about DexCom listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.157 | Earnings Share 1.65 | Revenue Per Share 10.089 | Quarterly Revenue Growth 0.02 | Return On Assets 0.0606 |
The market value of DexCom Inc is measured differently than its book value, which is the value of DexCom that is recorded on the company's balance sheet. Investors also form their own opinion of DexCom's value that differs from its market value or its book value, called intrinsic value, which is DexCom's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because DexCom's market value can be influenced by many factors that don't directly affect DexCom's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between DexCom's value and its price as these two are different measures arrived at by different means. Investors typically determine if DexCom is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, DexCom's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.